NIKKI KADRYNA: Open Payments
NPI 1730105271 · SELINSGROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 14 payments from 7 companies in 2025. Trend: 2023 $381 · 2024 $339 · 2025 $245
Food & beverage: $229Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $69 |
| Lilly USA, LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| ABBVIE INC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: MOUNJARO, Rybelsus, BREZTRI, ROTATEQ, Wegovy, QULIPTA, JARDIANCE, XIFAXAN.
Industry payments across PA — which companies pay providers there.
